Severe tricuspid regurgitation was associated with a higher risk of 1-year all-cause mortality compared with nonsevere tricuspid regurgitation (adjusted HR 1.38; 95% CI 1.01-1.88; P=0.042).
Observational (n=1,085)
Sí
Does severe tricuspid regurgitation increase the risk of all-cause mortality in patients with advanced heart failure?
In patients with advanced heart failure, severe tricuspid regurgitation is independently associated with an increased risk of all-cause mortality.
Estimación del efecto: adjusted HR 1.38 (95% CI 1.01-1.88)
valor p: p=0.042
AIMS: To evaluate the role of tricuspid regurgitation in advanced heart failure. METHODS: The multicenter observational HELP-HF registry enrolled consecutive patients with heart failure and at least one 'I NEED HELP' criterion evaluated at four Italian centers between January 2020 and November 2021. Patients with no data on tricuspid regurgitation and/or receiving tricuspid valve intervention during follow-up were excluded. The population was stratified by no/mild tricuspid regurgitation vs. moderate tricuspid regurgitation vs. severe tricuspid regurgitation. Variables independently associated with tricuspid regurgitation, as well as the association between tricuspid regurgitation and clinical outcomes were investigated. The primary outcome was all-cause mortality. RESULTS: Among the 1085 patients included in this study, 508 (46.8%) had no/mild tricuspid regurgitation, 373 (34.4%) had moderate tricuspid regurgitation and 204 (18.8%) had severe tricuspid regurgitation. History of atrial fibrillation, any prior valve surgery, high dose of furosemide, preserved left ventricular ejection fraction, moderate/severe mitral regurgitation and pulmonary hypertension were found to be independently associated with an increased likelihood of severe tricuspid regurgitation. Estimated rates of 1-year all-cause death were of 21.4, 24.5 and 37.1% in no/mild tricuspid regurgitation, moderate tricuspid regurgitation and severe tricuspid regurgitation, respectively (log-rank P < 0.001). As compared with nonsevere tricuspid regurgitation, severe tricuspid regurgitation was independently associated with a higher risk of all-cause mortality (adjusted hazard ratio 1.38, 95% confidence interval 1.01-1.88, P = 0.042), whereas moderate tricuspid regurgitation did not. CONCLUSION: In a contemporary, real-world cohort of patients with advanced heart failure, several clinical and echocardiographic characteristics are associated with an increased likelihood of severe tricuspid regurgitation. Patients with severe tricuspid regurgitation have an increased risk of mortality.
Pagnesi et al. (Tue,) conducted a observational in advanced heart failure (n=1,085). Severe tricuspid regurgitation vs. Nonsevere tricuspid regurgitation was evaluated on all-cause mortality (adjusted HR 1.38, 95% CI 1.01-1.88, p=0.042). Severe tricuspid regurgitation was associated with a higher risk of 1-year all-cause mortality compared with nonsevere tricuspid regurgitation (adjusted HR 1.38; 95% CI 1.01-1.88; P=0.042).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: